High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial-Reference-Cited by-同舟云学术

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial

Published:2021-09 Issue: Volume:162 Page:60-67
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Patel Roshal R.^ORCID,He Kewen,Barsoumian Hampartsoum B.,Chang Joe Y.,Tang Chad,Verma Vivek^ORCID,Comeaux Nathan^ORCID,Chun Stephen G.,Gandhi Saumil,Truong Mylene T.^ORCID,Erasmus Jeremy J.,Hong David S.,Lee Percy P.,Ning Matthew S.,Nguyen Quynh-Nhu,Heymach John V.,Altan Mehmet,Blumenschein George,Fossella Frank V.,Sezen Duygu^ORCID,Chen Dawei,Carter Brett W.,Davies Michael A.,Glitza Isabella C.,Diab Adi,Ferrarotto Renata,Cabanillas Maria E.,Yuan Ying,Shah Shalin J.^ORCID,Parra Edwin R.^ORCID,Sun Baohua,Cortez Maria Angelica,Welsh James W.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference70 articles.

1. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N Engl J Med,2018

2. Three-year overall survival with durvalumab after chemoradiotherapy in stage III NSCLC-update from Pacific;Gray;J Thorac Oncol,2020

3. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study;Hui;Lancet Oncol,2019

4. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial;Kwon;Lancet Oncol,2014

5. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions;Cancer Letters;2024-11

2. Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review;Frontiers in Oncology;2024-07-16

3. Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review;Critical Reviews in Oncology/Hematology;2024-07

4. Spatially Fractionated Radiotherapy in the Era of Immunotherapy;Seminars in Radiation Oncology;2024-07

5. Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy;British Journal of Radiology;2024-06-04